Global Spina Bifida Treatment Market - Industry Trends and Forecast to 2029

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

Global Spina Bifida Treatment Market - Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Global Spina Bifida Treatment Market

市场规模(十亿美元)

CAGR :  % Diagram

Chart Image USD 2.42 Billion USD 4.61 Billion 2021 2029
Diagram Forecast Period
2022 –2029
Diagram Market Size (Base Year)
USD 2.42 Billion
Diagram Market Size (Forecast Year)
USD 4.61 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Pfizer
  • Regeneron Pharmaceuticals
  • Astellas Pharma
  • Merck KGaA
  • Sanofi

>Global Spina Bifida Treatment Market, By Disorder (Meningocele, occulta, myelomeningocele, and Closed Neural Tube Defects), Type (Spina Bifida Cystica, Spina Bifida Occulta), Treatment (Medicines, Medical Procedures, Surgeries, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.

Spina Bifida Treatment Market

Spina Bifida Treatment Market Analysis and Size

The spina bifida treatment market is expected to witness significant growth during the forecast period. Spina bifida is a congenital condition that usually occurs as a result of mutation in the spinal cord. This condition affects women more than men. Factors such as obesity, diabetes, and folate deficiency are considered risk factors for the incidence of the condition.

Data Bridge Market Research analyses a growth rate in the spina bifida treatment market in the forecast period 2022-2029. The expected CAGR of global spina bifida treatment market is tend to be around 8.40% in the mentioned forecast period. The market was valued at USD 2.42 billion in 2021, and it would grow upto USD 4.61  billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Spina Bifida Treatment Market Scope and Segmentation

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2014 - 2019)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Disorder (Meningocele, occulta, myelomeningocele, and Closed Neural Tube Defects), Type (Spina Bifida Cystica, Spina Bifida Occulta), Treatment (Medicines, Medical Procedures, Surgeries, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Pfizer Inc. (U.S.), Regeneron Pharmaceuticals Inc (U.S.), Astellas Pharma Inc. (Japan), Merck KGaA (Germany), Sanofi (France), Bio-Rad Laboratories, Inc. (U.S.), Biocare Medical, LLC (U.S.), Lilly (U.S.), Teva Pharmaceutical Industries (Israel), B. Braun SE (Germany), Cardinal Health (U.S.), BD (U.S.), Boston Scientific Corporation (U.S.), Hologic, Inc. (U.S.)

Market Opportunities

  • Increase in Spina Bifida
  • Increasing Demand for Retail Pharmacies

Market Definition

Spina bifida is a kind of congenital defect affecting the spine and spinal cord and regularly appearing at birth. It is typically characterized by fragmented growth of the brain and spinal cord. This condition causes difficulties with bladder control and cognitive challenge. It can happen at any position along the spinal cord in case neural tube does not close properly. This causes defect in the formation and closure of backbone that protects the spinal cord. It often leads to damage of spinal cord and nerves associated with it.   

Global Spina Bifida Treatment Market Dynamics

Drivers

  • Rising Awareness of the Disease

The increasing technological advancements is the primary factor driving the spina bifida treatment market. With the rising awareness about the disease, market players are bringing in much innovations due to technological advancements. For instance, in Nov 2015, B. Braun Melsungen AG announced the launch of Ster-ASSIST Sterile Peripheral IV Catheter Insertion Kit. In the same year, Medtronic acquired Twelve, Inc., a trans-catheter mitral valve replacement device developer.

  • Increase in Elderly Population

As per the reports of the National Institute on Aging, around 524 million individuals, were above the age of 65 in the year 2010. This number is expected to rise and reach upto 1.5 billion, which is approximately 16% of the global population, by 2050. This boost the market growth.

Opportunities

  • Increase in Spina Bifida

It has been witnessed that in the U.S, 1,500 to 2,000 of the more than 4 million babies born are affected by the condition each year. In the U.S., around 166,000 individuals are living with this condition. It is more common among the population with fair complexion. It is more commonly observed among women as compared to men.

  • Increasing Demand for Retail Pharmacies

The rise in the number of spina bifida drugs delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

 Restraints/Challenges

  • Development of Complications

There are sevral complications associated with the use of NGF and these could curb the growth of the global nerve growth factor (NGF) market  over a forecast period. Excessively high levels of NGF have also been linked to cancer tumor growth, asthma, and the worsening of acquired immunodeficiency syndrome (AIDS). All these factors restrict the growth of the market.

  • High Cost

The huge expenditure associated with these agents hamper the market growth. The treatment involves different types of surgeries which demands high cost , thus, hindering the growth expansion.

This spina bifida treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the spina bifida treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Spina Bifida Treatment Market Scope

The spina bifida treatment market is segmented on the basis of type, treatment, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Disorder

  • Meningocele
  • occulta
  • Myelomeningocele
  • Closed Neural Tube Defects

Type

  • Spina Bifida Cystica
  • Spina Bifida Occulta

Treatment

  • Medicines
  • Medical Procedure
  • Urinary diversion
  • Urinary catheterization
  • Enema
  • Surgeries
  • Caesarean section
  • Surgery of the spine
  • Fetal endoscopic surgery
  • Suprapubic cystostomy
  • Spinal fusion
  • Others

End User

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Spina Bifida Treatment Market Regional Analysis/Insights

The spina bifida treatment market is analyzed and market size insights and trends are provided by type, treatment, distribution channel and end-user as referenced above.

The major countries covered in the spina bifida treatment market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for spina bifida treatment market throughout the forecasted period due to the increase in research activities in this region and advanced healthcare facilities.

Asia-Pacific dominates the market due to the increasing awareness about the diseases and rapidly disposable income.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Spina Bifida Treatment Market Share Analysis

The spina bifida treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to spina bifida treatment market.

Key players operating in the spina bifida treatment market include:

  • Pfizer Inc.(U.S.)
  • Regeneron Pharmaceuticals Inc (U.S.)
  • Astellas Pharma Inc. (Japan)
  • Merck KGaA (Germany)
  • Sanofi (France)
  • Bio-Rad Laboratories, Inc. (U.S.)
  • Biocare Medical, LLC (U.S.)
  • Lilly (U.S.)
  • Teva Pharmaceutical Industries (Israel)
  • B. Braun SE (Germany)
  • Cardinal Health (U.S.)
  • BD (U.S.)
  • Boston Scientific Corporation (U.S.)
  • Hologic, Inc. (U.S.)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

数据收集和基准年分析是使用具有大样本量的数据收集模块完成的。该阶段包括通过各种来源和策略获取市场信息或相关数据。它包括提前检查和规划从过去获得的所有数据。它同样包括检查不同信息源中出现的信息不一致。使用市场统计和连贯模型分析和估计市场数据。此外,市场份额分析和关键趋势分析是市场报告中的主要成功因素。要了解更多信息,请请求分析师致电或下拉您的询问。

DBMR 研究团队使用的关键研究方法是数据三角测量,其中包括数据挖掘、数据变量对市场影响的分析和主要(行业专家)验证。数据模型包括供应商定位网格、市场时间线分析、市场概览和指南、公司定位网格、专利分析、定价分析、公司市场份额分析、测量标准、全球与区域和供应商份额分析。要了解有关研究方法的更多信息,请向我们的行业专家咨询。

可定制

Data Bridge Market Research 是高级形成性研究领域的领导者。我们为向现有和新客户提供符合其目标的数据和分析而感到自豪。报告可定制,包括目标品牌的价格趋势分析、了解其他国家的市场(索取国家列表)、临床试验结果数据、文献综述、翻新市场和产品基础分析。目标竞争对手的市场分析可以从基于技术的分析到市场组合策略进行分析。我们可以按照您所需的格式和数据样式添加您需要的任意数量的竞争对手数据。我们的分析师团队还可以为您提供原始 Excel 文件数据透视表(事实手册)中的数据,或者可以帮助您根据报告中的数据集创建演示文稿。

Frequently Asked Questions

市场是基于 , By Disorder (Meningocele, occulta, myelomeningocele, and Closed Neural Tube Defects), Type (Spina Bifida Cystica, Spina Bifida Occulta), Treatment (Medicines, Medical Procedures, Surgeries, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029. 进行细分的。
在2021年,Global Spina Bifida Treatment Market的规模估计为2.42 USD Billion美元。
Global Spina Bifida Treatment Market预计将在2022年至2029年的预测期内以CAGR 8.4%的速度增长。
市场上的主要参与者包括Pfizer , Regeneron Pharmaceuticals , Astellas Pharma , Merck KGaA, Sanofi, BioRad Laboratories , Biocare Medical LLC, Lilly, Teva Pharmaceutical Industries, B. Braun SE, Cardinal Health, BD, Boston Scientific Corporation, Hologic 。
该市场报告涵盖U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America的数据。
Testimonial